Vironika Overview
- Year Founded
-
2007
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Vironika General Information
Description
Developer of an early-stage drug discovery company designed to develop novel drugs to block deadly tumor viruses from forming cancers. The company's technology platform includes small molecule inhibitors that target viral proteins, enabling clinicians to eliminate tumor viruses in latent, hidden, and lytic forms.
Contact Information
Website
www.vironika.comCorporate Office
- 100 East Lancaster Avenue
- LIMR Room 133
- Wynnewood, PA 19096
- United States
Corporate Office
- 100 East Lancaster Avenue
- LIMR Room 133
- Wynnewood, PA 19096
- United States
Vironika Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 28-Apr-2026 | Completed | Out of Business | |||
| 5. Grant | 01-Jan-2021 | Completed | Generating Revenue | |||
| 4. Grant | 06-Aug-2019 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2019 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2018 | $3.14M | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 20-Jan-2017 | Completed | Generating Revenue |
Vironika FAQs
-
When was Vironika founded?
Vironika was founded in 2007.
-
Where is Vironika headquartered?
Vironika is headquartered in Wynnewood, PA.
-
What industry is Vironika in?
Vironika’s primary industry is Drug Discovery.
-
Is Vironika a private or public company?
Vironika is a Private company.
-
What is Vironika’s current revenue?
The current revenue for Vironika is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process